GWPH Stock Recovers on Regained Sativex Rights

GWPH stock is bouncing back from losses incurred earlier this month in light of missed earnings after GW Pharmaceuticals (NASDAQ:GWPH) announced that it had regained the rights to commercialize the cannabis-based medicine Sativex in the UK. The pharmaceutical cannabidiol maker published its fourth-quarter results at the end of February, which missed analysts’ estimates and led to a sizeable drop off in GWPH stock. For the fourth quarter, GW Pharma reported a net loss per share of $0.07 compared with the expected figure of $0.04. Elsewhere, the British firm actually performed quite well, with revenue surging from … Read The Full Article On PotStockNews.com Get the latest marijuana stock news, cannabis on stock news on PotStockNews All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.

Excerpt only …
READ MORE BELOW
Source : pot stock
Link to original : GWPH Stock Recovers on Regained Sativex Rights
reposted by Cannabis News World